[ Evolve Biosystems raises $20M in Series B ]

Evolve Biosystems has raised $20 million in Series B funding.

Founded in 2011, Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. It develops and commercializes probiotic biotherapeutics to establish, restore, and maintain microbiome for various clinical needs.

The funds will support ongoing clinical activities, operational expansion, and the launch of the company’s unique, activated probiotic and prebiotic products, which restore the infant gut microbiome to its natural state, allowing proper metabolic and immune development. It will also support the development and commercialization of additional animal health products, which aim to restore the balance of nursing animals’ microbiome.

Funding  Series B
Founded  2011
Country  USA
City  Davis, California
Founder / CEO  David Kyle
Deal Size  $20M
Investors  Spruce Capital Partners
 Horizons Ventures
 Acre Venture Partners
 Bow Capital
 Tate & Lyle Ventures
Previous Investors  Horizons Ventures
 Tate & Lyle Ventures